Clinical Trials and COVID-19: Shaping of Agenda, Policies and Practices for a Transparent Future

Map Unavailable

Date(s) - 28/04/2022
15:00 CEST - 16:00 CEST

Categories No Categories

The outbreak of the COVID-19 pandemic, and the rapid development of associated vaccines and therapeutics, has driven a renewed interest and attention for clinical trials. In doing so, it has highlighted the importance of the integrity of the whole process. However, this should not take the focus away from other structural elements in the management of clinical trials, namely the need for greater transparency and accessibility to clinical data.

Health Action International and TranspariMED invite you to an online roundtable to share and gather feedback on a pending joint publication that we hope will contribute to ongoing discussions on clinical trial transparency at the World Health Organization, European Union, and at national level.


  • Jaume Vidal, Senior Policy Advisor, HAI
  • Till Bruckner, Founder, TranspariMED
  • Emma Thompson, Advocacy and Partnerships Manager, Cochrane


Register here to join the discussion: